CompletedPhase 2

Study to Evaluate the Use of Tilapia Skin (Oreochromis Niloticus), in the Treatment of Burn Wounds

63 participantsStarted 2016-10-05

Plain-language summary

Randomised Clinical Study to evaluate the efficacy of Nile tilapia (Oreochromis niloticus) skin as an occlusive biological dressing, in the treatment of humans burn wounds.

Who can participate

Age range

18 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of a dermatological wound caused by superficial second-degree burn with up to 20% of the body surface or deep second degree with area of 5 to 15% of the body surface; * Absence of previous treatment for the current burn * Without other significant diseases that could impact their participation in the study Exclusion Criteria: * Hypersensitivity to materials used in the study or to related compounds; * History of serious adverse reactions; * Addiction to drugs, including alcohol; * Pregnancy * Labor or miscarriage in the 12 weeks prior to the scheduled start of treatment.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of days for complete re-epithelization in study A and B

Timeframe: Day 11

Number of days for complete re-epithelization in study C

Timeframe: Day 21

The number of dressings performed as needed in study A and B

Timeframe: Day 11

The number of dressings performed as needed in study C

Timeframe: Day 21

Amount of anesthetics or analgesics used throughout the treatment in study A and B

Timeframe: Day 11

Amount of anesthetics or analgesics used throughout the treatment in study C

Timeframe: Day 21

Trial details

NCT IDNCT03592498

SponsorNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-09-20

View on ClinicalTrials.gov More Burns trials

Who can participate

Age range

18 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of days for complete re-epithelization in study A and B

Timeframe: Day 11

Number of days for complete re-epithelization in study C

Timeframe: Day 21

The number of dressings performed as needed in study A and B

Timeframe: Day 11

The number of dressings performed as needed in study C

Timeframe: Day 21

Amount of anesthetics or analgesics used throughout the treatment in study A and B

Timeframe: Day 11

Amount of anesthetics or analgesics used throughout the treatment in study C

Timeframe: Day 21